These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11228650)

  • 1. Steroids and endometrial breakthrough bleeding. Proceedings of a meeting. Melbourne, Australia, 4-5 May 1999.
    Hum Reprod; 2000 Aug; 15 Suppl 3():i-ii, 1-207. PubMed ID: 11228650
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroids and endometrial breakthrough bleeding: future directions for research.
    Smith SK
    Hum Reprod; 2000 Aug; 15 Suppl 3():197-202. PubMed ID: 11041236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modern approach to postmenopausal HRT: trading bleeding with safety.
    Al-Azzawi F; Wahab M
    Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766
    [No Abstract]   [Full Text] [Related]  

  • 4. The uterus and the menopause.
    Rees MC
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial structural and inflammatory changes with exogenous progestogens.
    Hickey M; Salamonsen LA
    Trends Endocrinol Metab; 2008 Jul; 19(5):167-74. PubMed ID: 18434186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unscheduled bleeding in continuous combined hormone therapy users.
    Hickey M; Ameratunga D; Marino JL
    Maturitas; 2011 Dec; 70(4):400-3. PubMed ID: 22030385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension.
    Sriprasert I; Beydoun H; Barnabei V; Nassir R; LaCroix AZ; Archer DF
    Menopause; 2015 Oct; 22(10):1067-75. PubMed ID: 25756697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception.
    Grow DR; Reece MT
    Hum Reprod; 2000 Aug; 15 Suppl 3():30-8. PubMed ID: 11041219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives].
    Gompel A
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S356-64. PubMed ID: 19268214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding with menopausal hormone therapy: physiological or pathological?
    Hickey M
    Menopause Int; 2007 Dec; 13(4):188-90. PubMed ID: 18088532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new hormone therapy problem: do we solve it with long-cycle progesterone therapy?
    Ravnikar V
    Menopause; 2005; 12(6):664-7. PubMed ID: 16278608
    [No Abstract]   [Full Text] [Related]  

  • 12. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin impairs human endometrial endothelial angiogenesis; implications for progestin-only contraceptive-induced abnormal uterine bleeding.
    Shapiro JP; Guzeloglu-Kayisli O; Kayisli UA; Semerci N; Huang SJ; Arlier S; Larsen K; Fadda P; Schatz F; Lockwood CJ
    Contraception; 2017 Jun; 95(6):592-601. PubMed ID: 28433626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal bleeding disturbances and implantable contraceptives.
    Hickey M; d'Arcangues C
    Contraception; 2002 Jan; 65(1):75-84. PubMed ID: 11861057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nylestriol on postmenopausal uterine endometrium].
    Liu JL
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):76-8, 122. PubMed ID: 8344085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry identification of potential mediators of progestin-only contraceptive-induced abnormal uterine bleeding in human endometrial stromal cells.
    Shapiro JP; Basar M; Kayisli UA; Guzeloglu-Kayisli O; Joseph Huang S; Suarez AA; Ozer HG; Schatz F; Lockwood CJ
    Contraception; 2015 Mar; 91(3):253-60. PubMed ID: 25529278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gynecologic complications of cyclic estrogen progestin therapy.
    Ettinger B; Selby JV; Citron JT; Ettinger VM; Zhang D
    Maturitas; 1993 Nov; 17(3):197-204. PubMed ID: 8133794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.